Hyperprothrombinemia
| Hyperprothrombinemia | |
| OMIM | 176930 |
|---|---|
| DiseasesDB | 32790 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Hyperprothrombinemia is a disorder of prothrombin which leads to hypercoagulation.
Substitution of adenine for guanine at position 20210 of the prothrombin gene, known as the prothrombin 20210a mutation, prothrombin 20210 mutation and, less precise, just factor II mutation,[1][2] leads to hypercoagulability and may be a factor that contributes to infertility. Its prevalence is thought to be approximately 2% in caucasians and 0.5% in blacks.[2]
Position 20210 falls outside of the reading frame for the protein and is thought to play a role in promoting prothrombin production; the substitution leads to high levels of prothrombin.[3]
References
- ↑ Steen CJ. Factor II. eMedicine.com. URL: http://www.emedicine.com/med/topic3494.htm. Accessed on: March 11, 2007.
- ↑ 2.0 2.1 Varga E, Moll S (2004). "Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation)". Circulation 110 (3): e15–8. doi:10.1161/01.CIR.0000135582.53444.87. PMID 15262854. Free Full Text.
- ↑ Poort S, Rosendaal F, Reitsma P, Bertina R (1996). "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis". Blood 88 (10): 3698–703. PMID 8916933.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
